TXNRD1 and cancer: Similar to GPX4, many types of cancer cells show a particular dependence on TXNRD1 for survival and the enzyme has thus been the focus for drug development projects aimed at identifying inhibitors of TXNRD1, hypothesizing that such compounds may have anticancer properties [14,[17], [18], [19]].